Speakers: Hannah H. England (Freeman), Jacqueline Grise, Zachary D. Goodwin
On this Ropes & Gray podcast, strategic transactions partner
Hannah England is joined by antitrust partners Jackie Grise and Zak
Goodwin to discuss the practical implications of the new
Hart–Scott–Rodino ("HSR") Act rules, which go
into effect on February 10, 2025, and the challenges faced by
pharmaceutical clients and the strategic adjustments required for
compliance. Tune in to understand how these changes will affect
acquisitions, licensing and collaboration transactions and other
strategic transactions, as well as the overall regulatory
landscape.
Transcript:
Hannah England: Hello, and welcome to our Ropes
& Gray podcast series on the new Hart–Scott–Rodino
("HSR") Act rules, with this first episode focused on
impacts to the pharmaceutical industry. My name is Hannah England,
and I'm a partner in our strategic transactions practice based
in Boston. I represent large